Characterization of D-fenfluramine-induced hypothermia: Evidence for multiple sites of action

European Journal of Pharmacology

Volumn 390, Issue 3, 2000, Pages 275-285

  Cryan, John F ^a   Harkin, Andrew ^a   Naughton, Marie ^a   Kelly, John P ^a   Leonard, Brian E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

5 HT(1A) receptor; D Fenfluramine; Haloperidol; Hypothermia; Ketanserin; Parachlorophenylalanine; RO 43 0440; Sertraline; Sulpiride; WAY 100635; Yohimbine

Indexed keywords

BENZOFURAN 2 CARBOXAMIDINE; BIOGENIC AMINE; DEXFENFLURAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FENCLONINE; HALOPERIDOL; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RECEPTOR SUBTYPE; RO 43 0440; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; ENVIRONMENTAL TEMPERATURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BENZOFURANS; BODY TEMPERATURE; CEREBRAL CORTEX; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENCLONINE; FENFLURAMINE; HALOPERIDOL; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; HYPOTHERMIA; KETANSERIN; MALE; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SULPIRIDE; YOHIMBINE;

EID: 0034598969     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00012-1     Document Type: Article

References (67)

1. Auerbach S.B., Minzenberg M.J., Wilkinson L.O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499:1989;281-289.
2. Aulakh C.S., Mallolo-Pomietto P., Wozniak K.M., Hill J.L., Murphy D.L. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hypothermia in rats is mediated by serotonin-2A receptors. J. Pharmacol. Exp. Ther. 270:1994;127-132.
3. Balciogu A., Wurtman R.J. Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotonergic mechanism. J. Pharmacol. Exp. Ther. 284:1998;991-997.
4. Baumann M.H., Ayestas M.A., Rothman R.B. In vivo correlates of central serotonin function after high-dose fenfluramine administration. Ann. N. Y. Acad. Sci. 844:1998;138-152.
5. Brogden R.N., Sorkin E.M. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in hypertension and peripheral vascular disease. Drugs. 40:1990;903-949.
6. Caccia S., Anelli M., Fracasso C., Frittoli E., Giorcelli P., Gobbie M., Taddei C., Garattini S., Mennini T. Anorectic effect and brain concentrations of D-fenfluramine in the marmoset; relationship to the in vivo and in vitro effects on serotonergic mechanisms. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;306-312.
7. Callaway C.W., Wing L.L., Nichols D.E., Geyer M.A. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Psychopharmacology. 111:1993;169-178.
8. Clausing P., Newport G.D., Bowyer J.F. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of D-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. J. Pharmacol. Exp. Ther. 284:1998;618-624.
9. Cleare A.J., Murray R.M., O'Keane V. Reduced prolactin and cortisol responses to D-fenfluramine in depressed patients as compared to healthy matched controls. Neuropsychopharmacology. 14:1996;349-354.
10. Cryan J.F., Kelliher P., Kelly J.P., Leonard B.E. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100653. J. Psychopharmacol. 13:1999;265-270.
11. Cryan J.F., McGrath C., Leonard B.E., Norman T.R. Combining pindolol and paroxetine in an animal model of chronic antidepressant action - can early onset of action be detected? Eur. J. Pharmacol. 352:1998;23-28.
12. Cryan J.F., McGrath C., Leonard B.E., Norman T.R. Onset of the effects of the 5-HT1A receptor antagonist WAY-100635, alone and in combination with paroxetine on olfactory bulbectomy and 8 OH-DPAT-induced changes in the rat. Pharmacol. Biochem. Behav. 63:1999;333-338.
13. Cryan J.F., Redmond A.M., Kelly J.P., Leonard B.E. The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat. Eur. Neuropsychopharmacol. 7:1997;109-114.
14. Curzon G., Gibson E.L., Oluyomi A.O. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol. Sci. 18:1997;21-25.
15. De Deurwardere P., Bonhomme N., Le Moel M., Spampinato U. D-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. J. Neurochem. 65:1995;1100-1103.
16. De Vry J. 5-HT1A agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-32.
17. Feeney S., Goodall E., Silverstone T. The effects of D-and L-fenfluramine (and their interactions with D-amphetamine) on cortisol secretion. Int. Clin. Psychopharmacol. 8:1993;139-142.
18. Fletcher A., Forester E.A., Bill D.J., Brown G., Cliffe I.A., Hartley J.E., Jones D.E., Mclenachan A., Stanhope K.J., Critchley D.J.P., Childs K.J., Middlefell V.C., Lanfumey L., Corradetti R., LaPorte A., Gozlan H., Hamon M., Dourish C.T. Electrophysiological, biochemical, neurohormonal and behavioral studies with WAY 100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
19. Frey H. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat. Pharmacology. 13:1975;163-176.
20. Garattini S., Mennini T., Samanin R. From fenfluramine racemate to D-fenfluramine. Ann. N. Y. Acad. Sci. 499:1987;156-166.
21. Gibson E.L., Kennedy A.J., Curzon G. D-Fenfluramine and D-norfenfluramine-induced hypophagia - differential mechanism and involvement of post-synaptical 5-HT receptors. Eur. J. Pharmacol. 242:1993;83-90.
22. Gobbi M., Parazzohi A., Mennini T. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;323-327.
23. Goodwin G.M., De Souza R.J., Green A.R. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature. 317:1985;531-533.
24. Harkin A.J., Kelly J.P., Frawley J., O'Donnell J.M., Leonard B.E. Test conditions influence the response to a drug challenge in rodents. Pharmacol. Biochem. Behav. 2000;. in press.
25. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond A., Leonard B.E. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur. J. Pharmacol. 364:1999;123-132.
26. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J. Neural Transm. 61:1985;131-135.
27. Hoyer D. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. Fozard J. Peripheral Actions of 5-HT. 1989;72-99 Oxford Univ. Press, Oxford.
28. Hutson P.H., Donohoe T.P., Curzon G. Hypothermia induced by the putative 5-HT1A agonists LY-165163 and 8-0H DPAT is not prevented by 5-HT depletion. Eur. J. Pharmacol. 143:1987;221-228.
29. Jespersen S., Bonaccorsi A., Garattini S. Fenfluramine and body temperature. J. Pharm. Pharmacol. 21:1969;558-559.
30. Kennett G.A., Curzon G. Potencies of antagonists indicate that 5-HT2C receptors mediate mCPP-induced hypophagia. Br. J. Pharmacol. 103:1991;2016-2020.
31. Kennett G.A., Pittaway T.P., Blackburn T.P. Evidence that 5-HT receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety. Psychopharmacology. 114:1994;90-96.
32. Kreiss D.S., Wieland S., Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52:1993;95-101.
33. Lesch K.P., Disselkamp-Tietze J., Schulte H.M. 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment. J. Neural Transm. 80:1990;157-161.
34. Lin M.T., Tsay H.J., Su W.H., Chueh F.Y. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. Am. J. Physiol. 274:1998;R1260-R1267.
35. Lin M.T., Wu J.J., Tsay B.L. Serotonergic mechanisms in the hypothalamus mediate thermoregulatory responses in rats. Nauyn-Schmiedeberg's Arch. Pharmacol. 322:1983;271-278.
36. Maj J., Moryl E. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J. Neural. Transm. 88:1992;143-156.
37. Malberg J.E., Seiden L.S. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Res. 765:1997;101-107.
38. 2C receptors. Psychopharmacology. 123:1996;333-339.
39. Menon M.K., Lloyd R.C., Filten L.J. Antagonism of the hypothermic effect of clozapine in mice by centrally active alpha-2-adrenergic antagonists and alpha-1-adrenergic agonists. Psychopharmacology. 101:1990;67-72.
40. Millan M.J., Audinot V., Rivet J.M., Gobert A., Vian J., Prost J.F., Spedding M., Peglion J.L. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur. J. Pharmacol. 260:1994;R3-R5.
41. Millan M.J., Rivet J.M., Canton H., Le Maouille-Girardon S., Gobert A. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J. Pharmacol. Exp. Ther. 264:1993;1364-1376.
42. Miller D.B., O'Callaghan J.P. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol. Neurobiol. 11:1995;177-192.
43. Minor B.G., Danyse W., Jonson G., Mohammed A.K., Post C., Archer T. Adaptive changes in alpha-2 adrenoceptor mediated responses: analgesia, hypothermia and hypoactivity. Pharmacol. Toxicol. 65:1989;143-151.
44. Myers R.D., Beleslin D.B., Revani A.H. Hypothermia: role of alpha-1 and alpha-2 noradrenergic receptors in the hypothalamus of the cat. Pharmacol. Biochem. Behav. 26:1987;373-379.
45. 2A receptor antagonists blocks MK-801-induced stereotypy and hyperlocomotion. Eur. J. Pharmacol. 358:1998;111-116.
46. Nsimba, S., 1995. An appraisal of the neuroleptic potential of rafoxanide in rats. MSc thesis, National University of Ireland.
47. Nunes J.C., Sharif N.A., Michel A.D., Whiting R.L. Dopamine-2 receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem. Res. 10:1991;1167-1174.
48. O'Callaghan J.P., Miller D.B. Neurotoxicity profile of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
49. O'Donnell J.M., Bangasz T., Koratis T. Altered thermoregulatory responses to clonidine in streptozocin-diabetes rats. Br. J. Pharmacol. 117:1996;938-942.
50. O'Keane V., Dinan T.G. Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsiveness of central serotonergic function. Am. J. Psychiatry. 148:1991;1009-1015.
51. O'Keane V., McLoughan D., Dinan T.G. D-Fenfluramine induced prolactin and cortisol release in major depression: response to treatment. J. Affective Disord. 26:1992;143-150.
52. Parada M.A., De Parada M.P., Rada R., Hemandez C. Sulpiride increases and dopamine decreases intracranial temperatures in rats when injected in the lateral hypothalamus: an animal model for the neuroleptic malignant syndrome. Brain Res. 674:1995;117-121.
53. Pitchot W., Ansseau M., Gonzalez-Moreno M., Lembreghts M., Hansenne M., Wauthy J., Reel C., Jammaer R., Papart P., Sullon J., Legros J.J. The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry. 28:1995;91-92.
54. Popov N., Pohle W., Rosler V., Matthies H. Regionale verteilung von gamma-aminobuttersaure, glutaminsaure, asparginsaure, dopamin, noradrenalin, serotonin im rattenhirn. Acta Med. Biol. Ger. 18:1967;695-702.
55. Preston E., Ma S., Hass N. Ambient temperature modulation of fenfluramine-induced thermogenesis in the rat. Neuropharmacology. 29:1990;277-283.
56. Quested D.J., Sargent P.A., Cowen P.J. Selective serotonin reuptake inhibitor treatment decrease the prolactin and hyperthermic responses to mCPP. Psychopharmacology. 133:1997;305-308.
57. Rose S., Hindmarsh J.G., Collins P., Jenner P. The effect of fenfluramine dosage regime and reduced food intake on levels of 5-HT in rat brain. J. Neural Transm. 104:1997;1339-1351.
58. Satinoff E., Kent S., Li H., Merigan D., Tomkowiak J.M. Circadian rhythms of body temperature and drinking and responses to thermal challenge in rats after PCPA. Pharmacol. Biochem. Behav. 38:1991;253-257.
59. Schwartz D., Hernandes L., Hoebel B.G. Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res. 585:1989;421-424.
60. Series H.G., Cowen P.G., Sharp T. p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and D-fenfluramine pretreatment attenuate D-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology. 116:1994;508-514.
61. Seyfried C.A., Adam G., Greve T. An automated direct-injection HPLC method for electrochemical/fluorometric quantitation of monoamines and related compounds optimized for screening a large number of animals. Biomed. Chromatogr. 1:1986;78-88.
62. Spedding M., Ouvery C., Millan M., Duhault J., Dacquet C. Neural control of dieting. Nature. 380:1996;488.
63. Stewart C.W., Bowyer J.F., Slikker W. Elevated environmental temperatures can induce hyperthermia during D-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain. J. Pharmacol. Exp. Ther. 283:1997;1144-1150.
64. Sugrue M.F. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake. Br. J. Pharmacol. 81:1984;651-657.
65. Sulpizio A., Fowler P.J., Macko E. Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition. Life Sci. 22:1978;1439-1446.
66. Won S.J., Lin M.T. 5-Hydroxytryptamine receptors in the hypothalamus mediate thermoregulaory responses in rabbits. Naunyn-Schmiedberg's Arch. Pharmacol. 338:1988;256-361.
67. Zarrindast M.R., Tabataba S.A. Involvement of dopamine receptor subtypes in mouse thermoregulation. Psychopharmacology. 107:1992;341-346.